Mirtazapine Grindeks (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonises postsynaptic 5‑HT2 and 5‑HT3 receptors, shifting serotonergic activity toward the 5‑HT1 pathway and enhancing overall neurotransmission linked to mood improvement.

The exact dose of mirtazapine is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Physicians typically start with a low dose and may adjust it gradually, but specific dosing regimens should only be provided by a qualified healthcare professional.

Safety data for mirtazapine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After verification of trade or institutional credentials, the sales team will respond with pricing, availability, shipping details (including any temperature‑controlled requirements) and necessary import documentation.

Mirtazapine differs from typical SSRIs by its dual antagonism of α2‑adrenergic and certain serotonin receptors, which often results in stronger sedative and appetite‑stimulating effects. This profile can be advantageous for patients with insomnia or weight loss, whereas SSRIs may have a lower risk of sedation but can cause different side‑effect patterns such as sexual dysfunction.

Store the product at ambient temperature, generally below 25 °C. Keep it in the original container, protect it from moisture and direct light, and ensure the packaging remains sealed until use. Do not refrigerate or freeze the tablets unless specifically instructed by the manufacturer.

Mirtazapine Grindeks is taken orally, usually once daily in the evening to take advantage of its sedative effect. It may be swallowed with or without food, but patients should follow the specific instructions provided by their prescriber or pharmacist.

Serious adverse events, although rare, include agranulocytosis or severe neutropenia, seizures, marked hypotension, and the emergence or worsening of suicidal thoughts or behaviors, especially during early treatment or dose changes. Prompt medical attention is required if any of these symptoms occur.

Mirtazapine should be avoided in patients with known hypersensitivity to the drug, those currently taking monoamine oxidase inhibitors (or within 14 days of stopping an MAOI), and individuals with severe hepatic impairment unless dose adjustments are made. Caution is also advised for patients with a history of bipolar disorder, as it may trigger manic episodes.